189 related articles for article (PubMed ID: 20882051)
1. Overexpression of survivin initiates hematologic malignancies in vivo.
Small S; Keerthivasan G; Huang Z; Gurbuxani S; Crispino JD
Leukemia; 2010 Nov; 24(11):1920-6. PubMed ID: 20882051
[TBL] [Abstract][Full Text] [Related]
2. [Advance of research on survivin in hematological malignancies--review].
Xiong HX; Chen BA; Ding JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):866-9. PubMed ID: 15631681
[TBL] [Abstract][Full Text] [Related]
3. An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy.
Zangemeister-Wittke U; Simon HU
Cell Cycle; 2004 Sep; 3(9):1121-3. PubMed ID: 15326382
[TBL] [Abstract][Full Text] [Related]
4. Survivin and leukemia.
Cong XL; Han ZC
Int J Hematol; 2004 Oct; 80(3):232-8. PubMed ID: 15540897
[TBL] [Abstract][Full Text] [Related]
5. Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells.
Leung CG; Xu Y; Mularski B; Liu H; Gurbuxani S; Crispino JD
J Exp Med; 2007 Jul; 204(7):1603-11. PubMed ID: 17576776
[TBL] [Abstract][Full Text] [Related]
6. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
[TBL] [Abstract][Full Text] [Related]
7. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
Wang Z; Sampath J; Fukuda S; Pelus LM
Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
[TBL] [Abstract][Full Text] [Related]
9. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
Endoh T; Tsuji N; Asanuma K; Yagihashi A; Watanabe N
Exp Cell Res; 2005 May; 305(2):300-11. PubMed ID: 15817155
[TBL] [Abstract][Full Text] [Related]
10. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells.
Fukuda S; Foster RG; Porter SB; Pelus LM
Blood; 2002 Oct; 100(7):2463-71. PubMed ID: 12239157
[TBL] [Abstract][Full Text] [Related]
11. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT
Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665
[TBL] [Abstract][Full Text] [Related]
12. Survivin is not required for the endomitotic cell cycle of megakaryocytes.
Wen Q; Leung C; Huang Z; Small S; Reddi AL; Licht JD; Crispino JD
Blood; 2009 Jul; 114(1):153-6. PubMed ID: 19339696
[TBL] [Abstract][Full Text] [Related]
13. The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter.
Li Y; Xie M; Yang J; Yang D; Deng R; Wan Y; Yan B
Oncogene; 2006 Jun; 25(23):3296-306. PubMed ID: 16462771
[TBL] [Abstract][Full Text] [Related]
14. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
15. Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.
Xing Z; Conway EM; Kang C; Winoto A
J Exp Med; 2004 Jan; 199(1):69-80. PubMed ID: 14699085
[TBL] [Abstract][Full Text] [Related]
16. [Factors regulating expression of antiapoptosis gene survivin].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):969-74. PubMed ID: 16403261
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells.
Gong J; Lee J; Akio H; Schlegel PN; Shen R
Endocrinology; 2007 Sep; 148(9):4489-99. PubMed ID: 17584963
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.
Zhang M; Yang J; Li F
J Exp Clin Cancer Res; 2006 Sep; 25(3):391-402. PubMed ID: 17167980
[TBL] [Abstract][Full Text] [Related]
19. Survivin: an inhibitor of apoptosis in pediatric cancer.
Fangusaro JR; Caldas H; Jiang Y; Altura RA
Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
